Óscar Alejandro Bonilla-Sepulveda, Diana Carolina Giraldo-Santa


Introduction: Mastalgia is a frequent clinical symptom in general and gynecological medicine consultation. The objectives of this bibliographical review are: to define the diagnostic concept, classification and treatment of mastalgia.

Methods: literature search in Pubmed, Scielo, Cochrane and Google Scholar, using the MeSH terms: mastodynia, mastalgia, breast pain, chest pain. The search limits were: full texts in English and Spanish, in humans and published during the last 10 years.

Results: the physiopathology of the mastodynia is not caused by a single mechanism, but by different causes with independent pathways. The main mechanisms are hormonal, mammary density, neuropathic and extra-mammary.

Conclusion: It is important to know the pathophysiology and classification of mastodynia, due to its therapeutic implications and possible association with breast cancer.

Palabras clave

Mastodynia, Mastalgia, Pain; Review

Texto completo:



Davies EL, Gateley CA, Miers M, Mansel RE. The long-term course of mastalgia. J R Soc Med 1998; 91:462–464.

Dixon JM. Managing breast pain. Practitioner 1999; 243:484–486; 488–489; 491.

Ader DN, South-Paul J, Adera, Deuster PA. Cyclycal mastalgia: Prevalence and associated health and behavioral factors. J Psychosom Obstet Gynecol 2001; 22:71–76.

Gateley CA, Maddox PR, Pritchard GA, Sheridan W, Harrison BJ, Pye JK, et al. Plasma fatty acid profiles in benign breast disorders. Br J Surg 1992; 79:407–409.

Hughes LE, Mansel RE, Webster DJ, eds. Breast pain and nodularity. In: Benign disorders and diseases of the breast: concepts and clinical management. Philadelphia: Bailliere Tindall, 1989, pp 75–92.

Parlati E Travaglini A, Liberale I, menini E, Dell’Ácqua Al. Hormonal profile in benign breast disease: Endocrine status of cyclical mastalgia patients. J Endocrinol Invest 1988; 11:679–683.

Horrobin DF, Manku MS. Premenstrual syndrome and premenopausal breast pain (cyclical mastalgia): disorders of essential fatty acid (EFA) metabolism. Prostaglandins Leukot Essent Fatty Acids 1989; 37:255–261.

Preece PE, Richards AR, Owen GM. Mastalgia and total body water. Br Med J 1975; 4:498–500

Kumar S, Rai R, Das V, Dwivedi V, Kumar S, GG A. Visual analogue scale for assessing breast nodularity in non discrete lumpy breasts: the Lucknow Cardiff breast nodularity scale. The Breast 2010; 19:238–242

Wisbey JR, Kumar S, Mansel RE, Preece PE, Pye JK, Hughes LE. Natural history of breast pain. Lancet 1983;ii:672–674

Ernster VL, Mason L, Goodson WH. Effects of caffeine free diet on benign breast disease: a randomized trial. Surgery 1982; 91:263– 267

Klimberg SV. Etiology and management of breast pain. In: Bland KI, Copeland EM, eds. The Breast: Comprehensive Management of Benign and Malignant Diseases, 2nd Ed. Philadelphia: WB Saunders Co; 1998, pp 247–260.

Hadi MS. Sports brassiere: is it a solution for mastalgia? Breast J 2000; 6:407–409

Fox H, Walker RG, Heys SD. Are patients with mastalgia anxious, and does relaxation therapy help? Breast 1997;6: 138–142.

Russell LC. Caffeine restriction as initial treatment of breast pain. Nurse Pract 1989; 14:36–37.

Ernster VL, Goodson WHD, Hunt TK, Petrakis NL, Sickles, Mike R. Vitamin E and benign breast disease: A double-blind, randomized clinical trial. Surgery 1985; 97:490–494.

Shurks M, Glynn RJ, Rist PM, Tzourio C, Kurth T. Effects of vitamin E on stroke subtypes: meta-analysis of randomized controlled trials. BMJ 2010;341:c5702–1315. doi:10.1136/c5702

84. Sharma AK, Mishra SK, Salila M et al. Cyclical mastalgia: Is it a manifestation of aberration in lipid metabolism? Indian J Physiol Pharm 1994; 38:267–271.

Goyal A, Mansel RE. A randomized multicenter study of gamolenic acid (Efamast) with and without antioxidant vitamins and minerals in the management of mastalgia. Breast J 2005; 11:41–47

Colak T, Ipek T, Kanik A Efficacy of topical nonsteroidal antiinflammatory drugs in mastalgia treatment. J Am Coll Surg 2003; 196:525–530

Sutton GLC, O’Malley UP. Treatment of cyclical mastalgia with low-dose short-term danazol. Br J Clin Pract 1986; 40:68.

Fentiman IS, Powles TJ. Tamoxifen and benign breast problems. Lancet 1987; 26(8567):1070–1072.

Mansel RE, Dogliotti L. European Multicenter Trial of bromocriptine in cyclical mastalgia. Lancet 1990; 335:190–193.

Mansel RE, Goyal A, Preece P, Leinster S, Maddox PR (2004) European randomized multicenter study of goserelin (Zoladex) in the management of mastalgia. Am J Obstet Gynecol 2004; 191(6):1942–1949

Peters F. Multicenter study of gestrinone in cyclical breast pain. Lancet 1991; 339:205.

Uzan S, Denis C, Pomi V, Varin C. Double-blind trial of promegestone (R 5020) and lynestrenol in the treatment of benign breast disease. Eur J Obstet Gynecol Reprod Biol 1992; 43:219–227

Coney P, Washenik K, Langley RG, Harrison DD. Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials. Contraception 2001; 63:297–302

Steinbrunn BS, Zera RT, Rodriguez JL Mastalgia: tailoring treatment to type of breast pain. Postgrad Med 1997;102(5):183–184,187-9,193-4

Maddox PR, Harrison BJ, Mansel RE et al. Non-cyclical mastalgia:An improved classification and treatment. Br J Surg 1989; 76:901–904.

Enlaces refback

  • No hay ningún enlace refback.

Licencia de Creative Commons
Esta obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.



Revista CES Medicina/ ISSN Impreso:0120-8705; Electrónico:2215-9177

Facultad de Medicina, Universidad CES.

Ultima actualización Mayo 31 de 2019



Publicada desde 1987.


Universidad CES - Facultad de Medicina
Calle 10A No. 22 - 04 Tel: 444 05 55 Fax: 268 28 76 Correo electrónico: Medellín – Colombia